Nitric oxide Flashcards

1
Q

what are the main pharmacologic actions of NO

A
  1. Smooth muscle
    • relaxation
  2. Cell adhesion
    • decreased adhesion
  3. Inflammatory response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Endogenous nitric oxide (NO) is generated from

A

oxidation of the guanidine group of arginine. It is produced in macrophages and endothelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what enzyme synthesizes NO?

A

Nitric oxide synthase (3 isoforms)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the 3 isoforms of nitric oxide synthase

A

NOS-1 (neuronal nNOS)
NOS-2 (inducible iNOS)
NOS-3 (endothelial eNOS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

which NOS isoforms are constitutively active

A

NOS-1 and NOS-3 (neuronal and endothelial) both also require calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

where and when is iNOS (NOS-2) produced

A

in macrophages and smooth muscle cells. It exhibits transcriptional induction (no Calcium requirement)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

once NO is generated how does it cause vasodilation

A

NO interacts with the heme moiety of soluble guanyl cyclase in the cytoplasm of the cell activating it. The enzyme then converts GTP to cGMP which causes muscle relaxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

nitrous oxide N2O

A

anesthetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what inactivates NO

A

heme and free radicals superoxide (therefore the enzyme superoxide dismutase may increase NO’s duration of action)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

4 Inhibitors of Nitric Oxide

A
  1. L-arginine Derivatives (L-NMMA, L-NAME) (competitive inhibitors bind/block the arginine binding site)
  2. Inhibitors of nitric oxide synthase synthesis
  3. Inhibitor of binding of arginine to NOs
  4. Scavengers of NO (heme)

most are substrate analogues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

for what diagnosis would a NO inhibitor be a useful treatment

A

sepsis (to reduce peroxynitrite production)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

excess NO production results in the formation of

A

peroxynitrite which is toxic to cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what causes the detrimental effects of NO

A

generatation of several reactive nitrogen derivatives by interacting with molecular oxygen and superoxide radicals.

These oxides of nitrogen are highly reactive and unstable, interact with numerous proteins, lipids, nucleic acids and metabolize.

= free radical formation, nitrosation and irritant effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how does cGMP cause vasodilation

A

it de-phosphorylates myosin light chain leading to muscular relaxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the function of phosphodiesterase (PDE)

A

converts cGMP to GMP which would prevent cGMP’s vasodilation effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how does sildenafil (viagra) work

A

inhibits phosphodiesterase therefore preventing the break down of cGMP

17
Q

how does NO affect the immune system

A

inhibits white cell adhesion to the endothelial surface by decreasing the release of adhesion molecules such as E-selectin on the endothelial surface

may protect against ischemic and reperfusion injury

18
Q

how does NO affect the respiratory system

A

Nitric oxide improves cardiopulmonary function in adults with pulmonary hypertension and is approved for this indication (INOmax).

It is administered by inhalation.

It is also used in children with acute respiratory distress syndrome (ARDS). Nitric oxide also relaxes airway smooth muscle and acts as a bronchodilator.

19
Q

what is the role of NO in shock

A

Bacterial infection and lipopolysaccharide B activate inducible nitric oxide synthase (NOs-2) resulting in hypotension, shock and possible death. This effect is reversed by NO inhibitors such as the L-NMMA.

20
Q

how does atherosclerosis affect NO

A

Vascular plaque and endothelial damage in atherosclerosis results in impaired nitric oxide formation.

L-arginine and nitric oxide donors are useful in the treatment of atherosclerotic disorders

21
Q

what is NO’s affect on platelets

A

Nitric oxide is a potent inhibitor of platelet adhesion, activation, aggregation and regulates the release of serotonin, growth factors and thromboxane from platelets. Platelets also contain the constitutive and inducible NOs.

NO also indirectly enhances fibrinolysis by inhibiting the release of antiplasmin from the platelets.

22
Q

how is NO helpful in organ transplant

A

Nitric oxide acts as a cytoprotective agent and prevents cellular and platelet adhesion. (which prevents ischemic and reperfusion injury to the graft)

Dietary arginine supplements are helpful in the management of transplantation patients.

23
Q

Mechanism of Action of NO donnors

A

Primarily produce smooth muscle relaxation by releasing endogenous NO which produces the following effects.

A.	Stimulates guanyl cyclase
B.	Increased production of cGMP
C.	Dephosphorylation of myosin
24
Q

indications of inhaled NO

A

A. Selective pulmonary vasodilation
B. Treatment of newborn with persistent pulmonary hypotension (improves oxygenation)
C. Beneficial effects in cardiopulmonary bypass in adults, congestive heart disease, primary pulmonary hypertension, pulmonary edema , lung transplantation and sickle cell crisis.

25
Q

Nitric Oxide (INOMAX) route of adminstration, indications, and side effect

A

Inhalation, ACS, vasodilation

26
Q

nitroglycerine MOA and route of adminstration

A

NO doner, sublingual

27
Q

nitroglycerine indications and side effects

A

indications- pulmonary artery hypertension

side effects - hypotension

28
Q

hydralazine MOA and route of adminstration

A

NO donor and vasodilator

route- oral

29
Q

sildenafil MOA and route of administration

A

Phosphodiesterase inhibitor

route - oral

30
Q

sildenafil indications and side effects

A

hypertesion

side effect- hypotension, and drug interactions

31
Q

L-arginine MOA and route of administration

A

NO donor

route- oral

32
Q

L-arginine indication and side effect

A

ACS, vascular disease

side effect - hypotension